[1] Kyd JM, McGrath J, Krishnamurthy A. Mechanisms of bacterial resistance to antibiotics in infections of COPD patients[J]. Curr Drug Targets, 2011,12(4):521-530. [2] Fernaays MM, Lesse AJ, Sethi S, et al. Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary disease[J]. Infect Immun, 2006,74(6):3366-3374. [3] Kohri K, Ueki IF, Shim JJ, et al. Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor[J]. Eur Respir J, 2002,20(5):1263-1270. [4] Vareille M, Kieninger E, Edwards MR, et al. The airway epithelium: soldier in the fight against respiratory viruses[J]. Clin Microbiol Rev, 2011,24(1):210-229. [5] Escande F, Aubert JP, Porchet N, et al. Human mucin gene MUC5AC: organization of its 5'-region and central repetitiveregion[J]. Biochem J, 2001,358(Pt 3):763-772. [6] Kratzer C, Graninger W, Macfelda K, et al. Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae[J]. Wien Klin Wochenschr, 2007,119(9/10):297-302. [7] Leiva M, Ruiz-Bravo A, Moreno E, et al. Telithromycin inhibits the production of proinflammatory mediators and the activation of NF-kappaB in in vitro-stimulated murine cells[J]. FEMS Immunol Med Microbiol, 2008,53(3):343-350. [8] Song KS, Yoon JH, Kim KS, et al. c-Ets1 inhibits the interaction of NF-kappaB and CREB, and downregulatesIL-1beta-induced MUC5AC overproduction during airway inflammation[J]. Mucosal Immunol, 2012,5(2):207-215. [9] Lim JH, Kim HJ, Komatsu K, et al. Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways[J]. Am J Transl Res, 2009,1(3):300-311. [10] Morinaga Y, Yanagihara K, Miyashita N, et al. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells[J]. Pulm Pharmacol Ther, 2009,22(6):580-586. [11] Ishimoto H, Mukae H, Sakamoto N, et al. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin[J]. J Antimicrob Chemother, 2009,63(1):109-114. [12] Sugiyama K, Shirai R, Mukae H, et al. Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells[J]. Clin Exp Immunol, 2007,147(3):540-546. |